Psychopharmacology Research.
Expert-defined terms from the Professional Certificate in Psychopharmacology and Genetics course at London School of Planning and Management. Free to read, free to share, paired with a globally recognised certification pathway.
Agonist #
A drug that binds to a receptor and activates it, leading to a physiological response. Agonists can be full, partial, or inverse, depending on their ability to mimic the natural neurotransmitter.
Antagonist #
A drug that binds to a receptor without activating it, thereby preventing the receptor's natural neurotransmitter or an agonist from binding and causing a physiological response.
Autoreceptor #
A type of receptor located on the presynaptic neuron that regulates the release of neurotransmitters.
Behavioral Pharmacology #
The study of the effects of drugs on behavior and mental processes.
Bioavailability #
The fraction of a drug that reaches the systemic circulation after administration and is available to produce a pharmacological effect.
Blood #
brain barrier (BBB): A highly selective semipermeable membrane that separates the brain from the bloodstream, controlling the passage of substances into the central nervous system.
Cholinergic #
Pertaining to the neurotransmitter acetylcholine and its actions in the nervous system.
Dopamine #
A catecholamine neurotransmitter involved in motivation, reward, and motor control.
Downregulation #
A decrease in the number or sensitivity of receptors in response to chronic exposure to a drug or neurotransmitter.
Efficacy #
The ability of a drug to produce a desired effect under ideal or actual conditions.
Enzyme #
A protein that catalyzes a biochemical reaction.
GABA ( γ #
aminobutyric acid): The primary inhibitory neurotransmitter in the central nervous system, responsible for reducing neuronal excitability.
Glutamate #
The primary excitatory neurotransmitter in the central nervous system.
Half #
life: The time required for the concentration of a drug in the body to decrease by half.
Monoamine Oxidase Inhibitors (MAOIs) #
A class of antidepressant drugs that inhibit the enzyme monoamine oxidase, increasing the levels of neurotransmitters such as serotonin, norepinephrine, and dopamine.
Neurotransmitter #
A chemical substance released by a neuron to transmit a signal to another neuron or target cell.
Norepinephrine #
A catecholamine neurotransmitter involved in arousal, attention, and the stress response.
Pharmacodynamics #
The study of how drugs interact with biological systems to produce a pharmacological effect.
Pharmacokinetics #
The study of how the body handles a drug, including absorption, distribution, metabolism, and excretion.
Receptor #
A protein molecule on the surface of a cell that binds to specific drugs or neurotransmitters, triggering a response within the cell.
Serotonin #
A neurotransmitter involved in mood regulation, appetite, and sleep.
Side effect #
An unintended or secondary effect of a drug, often caused by its interaction with other bodily systems.
Synapse #
The junction between two neurons where neurotransmitters are released and received.
Tolerance #
A decrease in a drug's effectiveness over time, requiring higher doses to achieve the same effect.
Upregulation #
An increase in the number or sensitivity of receptors in response to chronic exposure to a drug or neurotransmitter.
Vesicle #
A small, membrane-bound sac within a neuron that stores neurotransmitters before release.
This glossary provides a comprehensive overview of key terms in psychopharmacolo… #
Understanding these terms is crucial for learners pursuing a Professional Certificate in Psychopharmacology and Genetics, as well as those interested in the broader field of neuroscience and mental health.
When studying psychopharmacology, it is important to recognize that drugs affect… #
Agonists and antagonists, for example, exert their influence by binding to receptors and either activating or inhibiting them, respectively. Understanding these interactions helps researchers develop new medications and tailor existing treatments for various psychiatric disorders.
Another key concept in psychopharmacology is the blood #
brain barrier, a semipermeable membrane that protects the brain from harmful substances while allowing necessary nutrients to pass through. Drugs targeting the central nervous system must cross this barrier to reach their intended targets, which can pose challenges for drug development.
Pharmacodynamics and pharmacokinetics are two critical aspects of drug action #
Pharmacodynamics focuses on how drugs interact with biological systems to produce a pharmacological effect, while pharmacokinetics examines how the body handles a drug, including absorption, distribution, metabolism, and excretion. Understanding both aspects is essential for predicting a drug's efficacy and potential side effects.
Finally, it is crucial to recognize that chronic exposure to drugs or neurotrans… #
These phenomena can complicate treatment and require careful monitoring and management.
In conclusion, this glossary offers a solid foundation for learners in psychopha… #
By understanding key terms and concepts, learners will be better equipped to engage with the course material and apply their knowledge to practical scenarios.